| BriefMD |
Monday, 26 October 2026 |
|
|
Your Dermatology Brief
The 5 most important of 186 new papers in your topics: Alopecia, Atopic Dermatitis, Laser Therapy, Melanoma, Wound Healing, Acne, Autoimmune Skin Disease, Basal Cell Carcinoma, Biologic Therapy in Dermatology, Bullous Pemphigoid, Cutaneous Lymphoma, Dermatologic Surgery, Hidradenitis Suppurativa, Mohs Surgery, Pemphigus, Psoriasis, Rosacea, Skin Cancer, Squamous Cell Carcinoma, Vitiligo
|
|
| Top pick randomized trial Nguyen L, Schneider SW, Herberger K. Lasers Med Sci. Oct 2026. | Findings | Hair density improvements reached 25.6 ± 7.0 % with triple therapy and 22.7 ± 3.4 % with dual therapy, compared to 4.9 ± 9.2 % in the EBD-only group. Hair thickness also improved in both serum groups. | | Bottom line | Laser-assisted delivery of growth factors enhances hair density (up to 25.6 ± 7.0 %) in patients with androgenetic alopecia. |
PubMed, PMID 42911445 | | phase ii trial, 200 patients Wang T, Li J, Liang Y, et al. J Am Acad Dermatol. Oct 2026. | Findings | In a 200‑patient phase‑2 RCT, QY201 10 mg BID produced an 84.7% EASI‑75 response at week 12 versus 18.5% with placebo (P<0.0001). Higher doses also improved IGA scores (up to 71.3% vs 12.4% placebo) and showed TEAEs in 75–90% of participants. | | Bottom line | QY201 10 mg BID markedly increases EASI‑75 response (84.7% vs 18.5% placebo) with a safety profile comparable to lower doses. |
PubMed, PMID 42901423 | | randomized trial, 70 patients Baracho VDS, Silva NCD, Godinho LF, et al. Wound Repair Regen. Jan 2026. | Findings | In 70 patients, the AL group had a 53% reduction in wound area, while the PL group had a 9% reduction (p < 0.001). | | Bottom line | 904 nm GaAs laser therapy accelerates chronic wound healing, reduces bacterial load, and improves tissue remodeling, supporting its use as an adjunct to standard care. |
PubMed, PMID 42921882 | | meta-analysis, 3,733,499 patients Stylianakis D, Solinas C, Petrelli F, et al. Eur J Clin Invest. Nov 2026. | Findings | In a systematic review of 12 observational studies involving 3,733,499 women (219,357 exposed), drug‑only ovulation induction was associated with a hazard ratio of 1.39 (95% CI 1.01‑1.92) for melanoma, while ART/IVF showed a near‑null hazard ratio of 1.09 (95% CI 0.81‑1.48). | | Bottom line | Drug‑only ovulation induction may increase melanoma risk (HR 1.39, 95% CI 1.01‑1.92), whereas ART/IVF does not show a clear association (HR 1.09, 95% CI 0.81‑1.48). |
PubMed, PMID 42924873 | | randomized trial, 96 patients Zhang R, Jiang H. Pak J Pharm Sci. Jan 2027. | Findings | Adjunctive local berberine injection led to a higher total effective healing rate at 3 months compared with surgery alone (87.5% vs. 68.8%; risk difference, 18.7%; 95% CI, 1.2% to 36.2%; P < 0.05). Berberine also significantly improved ulcer healing rate (mean difference, 16.7%; 95% CI, 9.5% to 23.9%; P < 0.01). | | Bottom line | Local berberine injections adjunctively improve ulcer healing following tibial transverse osteotomy in diabetic foot ulcers. |
PubMed, PMID 42924998 |
Also new in your topics |
| See all 186 papers from today Opens in your browser. No sign-in needed. |
Was this brief useful? Replies to this email come straight to me. Jonah |
|
|
Edit Dermatology topics
Your library
Unsubscribe from this brief
Summaries are AI-generated from PubMed abstracts for educational use. Check the source before it changes care. BriefMD, researchbrief.io
|
|